Titlesort descending Credit Type Event date Cost
Immuno-oncology Enduring $25.00
Immunomodulating therapies (overview) Enduring $25.00
Immunopathology: evaluation, assessment, and considerations Enduring $25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00
Natural Killer Cells and their use for Cancer Immunotherapy Enduring $25.00
Neurotoxicity across Cancer Modalities Enduring $25.00
Nonclinical Safety assessment of therapies targeting neoantigens
    • 1.00 Participation
 Enduring $25.00
Overview of Cancer Immunotherapies
    • 0.50 Participation
 Enduring $35.00
Quantitative systems pharmacology/ toxicology modeling for IO therapies Enduring $25.00
Regulatory Considerations for Cancer Immunotherapies:​ Preclinical Focus​ Enduring $25.00
Regulatory guidance: Introduction Enduring $25.00
Regulatory guidance: Introduction Enduring $25.00
Safety assessment outside of drug development (e.g. agrichemicals, cosmetics, food additives, etc.) Enduring $25.00
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) Enduring $25.00

Pages